Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nab-paclitaxel + gemcitabine vs tegafur + gemcitabine in resected pancreatic cancer
NCT04216758Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Jan 2020
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, tegafur in pancreatic adenocarcinoma (PDAC), sponsored by Fudan University. Status: unknown.
02
Drugs
paclitaxeltegafur
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT04216758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04216758.